AB
CALA

Amalgamated Bank’s Calithera Biosciences, Inc CALA Stock Holding History

Amalgamated Bank’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-513
Closed -$25K – 2188
2021
Q1 		$25K Hold
513
– – ﹤0.01% 1593
2020
Q4 		$50K Buy
513
+4
+0.8% +$351 ﹤0.01% 1561
2020
Q3 		$35K Sell
509
-13
-2% -$1.13K ﹤0.01% 1474
2020
Q2 		$55K Buy
+522
New +$62K ﹤0.01% 1446

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Amalgamated Bank's CALA Position: Q2 2021 in Review

Amalgamated Bank sold out of Calithera Biosciences, Inc (CALA) in Q2 2021, closing a stake of 513 shares — an estimated $25K sold.

Amalgamated Bank first reported a position in CALA in Q2 2020 and held it in 4 quarters. The position peaked at $55K in Q2 2020. 76 funds tracked by Wall St. Rank hold CALA as of Q2 2021.

  • Amalgamated Bank reported no remaining Calithera Biosciences, Inc position as of Q2 2021 after selling out during the quarter.
  • Amalgamated Bank sold 513 Calithera Biosciences, Inc shares in Q2 2021, an estimated $25K.
  • Amalgamated Bank first reported a position in Calithera Biosciences, Inc in Q2 2020 and held it in 4 quarters.
  • Amalgamated Bank's Calithera Biosciences, Inc position peaked at $55K in Q2 2020.
  • 76 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q2 2021.

Based on Amalgamated Bank's 13F filing for Q2 2021, filed 16 Aug 2021.